The Tough Tech problem we are solving
Precision diagnostics demand high accuracy and affordability, yet healthcare faces a stark trade-off: expensive lab-grade equipment inaccessible to underserved communities or low-cost tests plagued by false positives and poor reliability—widening equity gaps and delaying critical care.
About our solution
Hyperion Biosystems fuses AI, machine vision, and physics-based algorithms to unlock lab-grade performance from low-cost hardware, delivering 10x sensitivity gains in antigen and molecular panels without infrastructure overhauls. This democratizes exquisite diagnostics for remote providers, resource-limited settings, and global scale, minimizing disease impact through reliable, equitable detection.